We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+29.7%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.09B
AUM Growth
+$568M
(+109%)
Cap. Flow
+$422M
Cap. Flow
% of AUM
38.69%
Top 10 Holdings %
Top 10 Hldgs %
23.6%
Holding
197
New
132
Increased
39
Reduced
16
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$26.1M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$20M |
| 3 |
Arvinas
ARVN
|
+$19.8M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$19.7M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aprea Therapeutics
APRE
|
+$18.2M |
| 2 |
KYNB
Kyntra Bio
KYNB
|
+$12M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$10.7M |
| 4 |
Teladoc Health
TDOC
|
+$10.1M |
| 5 |
Biogen
BIIB
|
+$8.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.26% |
| 2 | Industrials | 4.93% |
| 3 | Technology | 1.47% |
| 4 | Energy | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Universal Health Services
UHS
$10.2B
| $1.05M | 0.1% |
+11,300
| New | +$1.13M |
|
102
Chemed
CHE
$7.07B
| $1.04M | 0.1% |
+2,300
| New | +$1.03M |
|
103
Illumina
ILMN
$31B
| $1.01M | 0.09% |
2,806
-6,374
| -69% | -$2.05M |
|
104
DaVita
DVA
$15.4B
| $1M | 0.09% |
+12,700
| New | +$992K |
|
105
Encompass Health
EHC
$11B
| $935K | 0.09% |
+18,981
| New | +$1.02M |
|
|
RNAM
106
DELISTED
Avidity Biosciences
RNAM
| $927K | 0.09% |
+32,803
| New | +$946K |
|
107
Jazz Pharmaceuticals
JAZZ
$15.9B
| $916K | 0.08% |
+8,300
| New | +$918K |
|
108
NovoCure
NVCR
$1.73B
| $907K | 0.08% |
+15,300
| New | +$1.01M |
|
109
Penumbra
PEN
$12.7B
| $876K | 0.08% |
+4,900
| New | +$850K |
|
|
LHCG
110
DELISTED
LHC Group LLC
LHCG
| $802K | 0.07% |
+4,600
| New | +$675K |
|
111
United Therapeutics
UTHR
$25.8B
| $799K | 0.07% |
+6,600
| New | +$743K |
|
|
AVEO
112
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $773K | 0.07% |
+150,000
| New | +$947K |
|
|
MYOK
113
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $734K | 0.07% |
+7,600
| New | +$634K |
|
114
Haemonetics
HAE
$3.89B
| $681K | 0.06% |
+7,600
| New | +$768K |
|
115
Ultragenyx Pharmaceutical
RARE
$2.45B
| $673K | 0.06% |
+8,600
| New | +$569K |
|
|
XLRN
116
DELISTED
Acceleron Pharma
XLRN
| $667K | 0.06% |
+7,000
| New | +$675K |
|
117
Arrowhead Research
ARWR
$11.9B
| $661K | 0.06% |
+15,300
| New | +$540K |
|
118
Bruker
BRKR
$9.57B
| $647K | 0.06% |
+15,900
| New | +$626K |
|
119
HealthEquity
HQY
$8.41B
| $628K | 0.06% |
+10,700
| New | +$592K |
|
120
Neogen
NEOG
$2.63B
| $621K | 0.06% |
+16,000
| New | +$541K |
|
121
Nektar Therapeutics
NKTR
$2.39B
| $618K | 0.06% |
+1,780
| New | +$555K |
|
|
NVRO
122
DELISTED
NEVRO CORP.
NVRO
| $609K | 0.06% |
+5,100
| New | +$605K |
|
|
BLUE
123
DELISTED
bluebird bio
BLUE
| $604K | 0.06% |
+764
| New | +$576K |
|
|
MNTA
124
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $599K | 0.06% |
+18,000
| New | +$573K |
|
125
Q32 Bio
QTTB
$466M
| $581K | 0.05% |
2,127
| – | – |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Sectoral Asset Management held 197 positions worth $1.09B, up 109% from $521M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sectoral Asset Management deployed $422M of net new capital in Q2 2020, opening 132 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 401,158 shares worth $25.5M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Aprea Therapeutics, an estimated $18.2M trimmed.
- Sectoral Asset Management's largest Q2 2020 buy was Centene: 401,158 shares worth $25.5M.
- Sectoral Asset Management added most to Cardiovascular Systems, Inc. in Q2 2020, an estimated $18.2M increase.
- Sectoral Asset Management's biggest Q2 2020 reduction was Aprea Therapeutics, cutting an estimated $18.2M.
- Sectoral Asset Management fully exited Inspire Medical Systems in Q2 2020, selling an estimated $6.81M.
- Sectoral Asset Management's ten largest holdings make up 24% of its $1.09B portfolio in Q2 2020.
- Sectoral Asset Management opened 132 new positions and closed 6 in Q2 2020.
- Sectoral Asset Management's portfolio value rose 109% quarter-over-quarter to $1.09B.
Based on Sectoral Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.